CHEM2052 Tutorial Example4
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
== '''Chem2052: Example 4 - Renin''' == | == '''Chem2052: Example 4 - Renin''' == | ||
| - | The spinning structure you initially view on this page is | + | The spinning structure you initially view on this page is a protease called Renin. Renin is an '''aspartyl protease''', which cleaves a particular peptide called angiotensinogen. |
== Background == | == Background == | ||
| Line 13: | Line 13: | ||
== '''Active Sites''' == | == '''Active Sites''' == | ||
| - | This representation illustrates the active site catalytic residues of Renin. | + | This representation illustrates the <scene name='59/596437/Renin_catalytic_residues/2'>active site catalytic residues</scene> of Renin. |
| - | <scene name='55/559112/ | + | |
| + | == '''Inhibition of Renin''' == | ||
| + | This scene shows the <scene name='55/559112/active site of renin with the Pfizer inhibitor bound/1'>Renin Catalytic Residues</scene>. Which part of the inhibibtor binds to the catalytic residues of the active site? | ||
| + | |||
<scene name='55/559112/Renin_catalytic_residues/1'>Renin Catalytic Residues</scene> | <scene name='55/559112/Renin_catalytic_residues/1'>Renin Catalytic Residues</scene> | ||
Revision as of 05:33, 13 August 2014
CHEM2052_Tutorial_Example4
| |||||||||||
References
- ↑ Powell NA, Ciske FL, Cai C, Holsworth DD, Mennen K, Van Huis CA, Jalaie M, Day J, Mastronardi M, McConnell P, Mochalkin I, Zhang E, Ryan MJ, Bryant J, Collard W, Ferreira S, Gu C, Collins R, Edmunds JJ. Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors. Bioorg Med Chem. 2007 Sep 1;15(17):5912-49. Epub 2007 Jun 2. PMID:17574423 doi:10.1016/j.bmc.2007.05.069
- ↑ Rawlings ND, Morton FR, Kok CY, Kong J, Barrett AJ. MEROPS: the peptidase database. Nucleic Acids Res. 2008 Jan;36(Database issue):D320-5. Epub 2007 Nov 8. PMID:17991683 doi:10.1093/nar/gkm954
- ↑ 3.0 3.1 Di Cera E. Serine proteases. IUBMB Life. 2009 May;61(5):510-5. PMID:19180666 doi:10.1002/iub.186

